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In vivo identiﬁcation of alteration of inner
neurosensory layers in branch retinal artery occlusion
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ABSTRACT
Background/aims To characterise the extension and
progression of alteration of neurosensory layers following
acute and chronic branch retinal artery occlusion (BRAO)
in vivo using spectral-domain optical coherence
tomography.
Methods In this observational case series, eight eyes
with acute BRAO and nine eyes with chronic BRAO were
analysed using a Spectralis Heidelberg Retina
Angiograph (HRA)+optical coherence tomography
system including eye tracking. Patients with acute BRAO
were examined within 3665 h after primary event and
at weekly/monthly intervals thereafter. Segmentation
measurements of all individual neurosensory layers were
performed on single A-scans at six locations in affected
and corresponding non-affected areas. The thickness
values of the retinal nerve ﬁbre layer together with the
ganglion cell layer (NFL/GCL), inner plexiform layer (IPL),
inner nuclear layer together with outer plexiform layer
(INL/OPL), outer nuclear layer (ONL), and photoreceptor
layers together with the retinal pigment epithelium (PR/
RPE) were measured and analysed.
Results Segmentation evaluation revealed a distinct
increase in thickness of inner neurosensory layers
including the NFL/GCL (35%), IPL (80%), INL/OPL (48%)
and mildly the ONL by 21% in acute ischaemia compared
with corresponding layers in non-ischaemic areas.
Regression of intraretinal oedema was followed by
persistent retinal atrophy with loss of differentiation
between IPL and INL/OPL at month 2. In contrast, the
ONL and subjacent PR/RPE retained their physiological
thickness in patients with chronic BRAO.
Conclusion In vivo assessment of retinal layer
morphology allows a precise identiﬁcation of the
pathophysiology in retinal ischaemia.
INTRODUCTION
Branch retinal artery occlusion (BRAO) is
a common vascular occlusive disorder of the eye,
representing 38% of all acute retinal artery
obstructions.
1 These occlusions are caused by
embolisation, coagulopathies, vasospasm or vascu-
litides, while distinct emboli are visible in up to
68% of cases.
2 Hypertension, carotid occlusive
disease or atherosclerosis, coronary artery disease
and hypercholesteraemia are systemic risk factors
predisposing patients to develop BRAO.
3 The
affected retina typically demonstrates a whitish
opaciﬁcation in the acute phase which peaks at
24 h and resolves thereafter.
4 Ischaemic retinal
injury results in initial loss of energy-dependent
cellular function,
56swelling
7 and an invariable
course of necrosis, pigmentary degeneration and
vascular involution.
8 BRAO occurs typically at
bifurcations and involves the temporal vessels in
98% of cases.
9
Visual outcomes have been reported at the level
of 20/40 or better for most affected eyes.
2 10e12 In
the light of the reports of good initial and consec-
utive visual acuity, aggressive management and
treatment are usually not pursued with BRAO
compared with events of central retina artery
occlusion (CRAO), associated with severe vision
loss at ﬁrst presentation.
Although the obvious clinical changes are well
described in BRAO, including swelling and opaciﬁ-
cation of the affected area, such ophthalmoscopic
observationsremainunspeciﬁc anddo notallowany
understanding of the pathophysiological effects of
severe ischaemia in a complete neurosensory struc-
ture. Recently, some investigations used optical
coherence tomography (OCT) to image retinal
alterations associated with BRAO.
13e16 In acute
BRAO, increased overall thickness and reﬂectivity
were noted in the inner retina with secondary
shadowing and attenuation of subjacent structures
supposedly due to intracellular oedema. A report by
Asefzadeh
17 showed no signiﬁcant change in OCT
ﬁndings after the 4-month visit, and this suggests
ad e ﬁnition of a BRAO of at least 4 months’ dura-
tion as chronic. Cases were characterised by local-
ised retinal atrophy; in particular the inner retina
had lost reﬂectivity and was attenuated.
18 However,
except for two case reports,
16 17 no detailed longi-
tudinal analysis of speciﬁc alterations within the
different neurosensory layers has been provided
as yet.
The natural course of retinal oedema and the
development of inner retinal atrophy might be of
particular interest with regard to the evaluation of
the effects of therapeutic interventions.
Recently, spectral-domain OCT (SD-OCT)
technology has been introduced with further
improvements in resolution and imaging speed.
Moreover, scans are performed in a raster pattern
throughout the entire macular area at a resolution
of 5 mm in axial and 20 mm in transverse direc-
tion.
19 Hence, ‘histologic’ layers of the retina may
be imaged distinctly in an attempt to identify
primary sites of injury and monitor progression or
regression of chronic changes. Evaluation of
microstructural alterations following BRAO may
allow a better understanding of the pathophysi-
ology of retinal ischaemia and corresponding
changes in retinal layers after BRAO.
Herein,wesystematicallyinvestigatedthespeciﬁc
morphological alterations of the retinal ultrastruc-
ture following BRAO at acute presentation and
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Clinical scienceduring follow-up as well as in chronic cases up to 5 years after
BRAO using SD-OCT technology.
MATERIALS AND METHODS
This prospective clinical trial was performed at the Department
of Ophthalmology, Medical University of Vienna, Austria, and
enrolled eight consecutive patients with acute BRAO and nine
patients with chronic BRAO. All the research and measurements
adhered to the tenets of the Declaration of Helsinki; the study
and the study procedures were approved by the local ethics
committee at the Medical University of Vienna; and an informed
consent was obtained from the subjects after explanation of
the nature and possible consequences of the study.
Patient selection
The diagnosis of BRAO was based on the presence of its classical
clinical ﬁndings including the documented history of sudden
onset of visual deterioration in one eye, ﬂuorescein angiography
showing absence and/or marked stasis of circulation in the
involved branch retinal artery as well as retinal swelling in
the dependent area of the occluded branch artery on fundus
examination.
Exclusion criteria included diabetes, the presence of other
retinal diseases in the study eye, such as age-related macular
degeneration, hereditary retinal dystrophies as well as any
history of retinal surgery or laser photocoagulation and ocular
hypertension or glaucoma.
Patients with acute BRAO (onset of ﬁrst symptoms #48 h)
were recruited from the emergency unit of the Department of
Ophthalmology of the Medical University of Vienna, and
patients with chronic BRAO (onset of symptoms $4 months)
were recruited from a list of patients with the clinical diagnosis
of BRAO at the retina unit.
Ophthalmic evaluation
All patients underwent an ophthalmic examination including
measurement of best corrected Snellen visual acuity (BCVA) and
intraocular pressure, slit-lamp examination, funduscopy and
OCT imaging at each follow-up time as well as ﬂuorescein
angiography at initial examination.
Patients with acute BRAO were examined using a Spectralis
OCT device (Heidelberg Engineering , Software Version 3.2) at
monthly intervals until month 3. In addition, three of these
patients agreed to weekly follow-up visits during the ﬁrst month.
Patients with chronic BRAO were examined in a single
session.
OCT imaging
All OCT examinations and measurements were performed
following a standardised study protocol for data acquisition and
analysis. Before examination, the pupil of the study eye was
dilated with 1% tropicamide (Mydriaticum ‘Agepha,’ Agepha,
Vienna, Austria) and 2.5% phenylephrine hydrochloride eye-
drops. A raster scan consisting of 31 B scans was used to image
the macular region. The size of the ﬁeld of view was 308.F o r
intraindividual follow-up examinations, the TruTrack automatic
retinal recognition system was used to place the scans in exactly
identical location. For the analysis of separate retinal layer
thickness, horizontal scans conﬁning the highest retinal thick-
ening in the area of BRAO (ﬁgure 1B) were compared with
Figure 1 Spectral-domain OCT scans
of a case with acute branch retinal
artery occlusion (BRAO), 24 h after the
ﬁrst symptoms (A, B) and 2 weeks
(C) and 2 months (D) thereafter. For
analysis of retinal layers, scans in the
area of BRAO (B, C, D) and as a normal
counterpart, in the anatomically
corresponding area in the non-involved
half of macula (A) were selected.
Retinal layers were manually
segmented as illustrated, and layer
thickness was measured at six
locations within the selected scans
(locations indicated by the six
perpendicular arrows). Swelling of the
inner retina is most notable in the
increased thickness of the inner
plexiform layer (IPL) followed by the
inner nuclear layer/inner plexiform layer
(INL/IPL) and nerve ﬁbre layer/ganglion
cell layer (NFL/GCL) (A, B). The IPL could
not be distinguished from the INL/IPL at
month 2 (D). The outer nuclear layer
(ONL) shows a slight increase in
thickness in the acute phase (A), and
the photoreceptor/retinal pigment
epithelium (PR/RPE) complex retained
stable thickness values during the entire
follow-up (B, C, D).
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Clinical sciencetopographically corresponding sites in the non-involved opposite
half of macula (ﬁgure 1A). The corresponding non-involved
region was identiﬁed by its equal distance from the central
(foveal) scan (ﬁgure 2).
Neurosensory layers were segmented using the manual
adjustment to the segmentation lines, and layer thickness was
measured at six different locations within the selected scans.
Segmentation measurements performed at each scan location
are illustrated in ﬁgure 1. Delineations include thicknesses of the
nerve ﬁbre layer/ganglion cell layer (NFL/GCL), inner plexiform
layer (IPL), inner nuclear layer/outer plexiform layer (INL/OPL),
outer nuclear layer (ONL) and photoreceptor layers together
with the retinal pigment epithelium (PR/RPE). In addition, the
mean retinal thickness was assessed.
To improve reliability, the segmentation measurements were
performed independently by two certiﬁed OCTreaders (MR and
GD) of the Vienna Reading Center, blinded from clinical data
regarding the BRAO and the results of the other reader.
Statistical analysis
All calculations were performed using SPSS for Windows Version
17.0. The mean of six measurements per scan was used to
calculate the difference between layer thickness in the affected
and unaffected areas. Statistical analysis was based on the
means of the two independent grading measurements. A two-
sided paired t test was used for analysis of changes in total
retinal and retinal layer thickness. A p value of #0.05 was
considered statistically signiﬁcant after Bonferroni multiple test
correction.
RESULTS
Demographics
The study comprised 11 male and six female patients with
a mean age of 70612 years (range: 55e89 years). Temporal
branch arteries were involved in all eyes with eight involving the
inferior macula and nine the superior macula. Patients with
acute BRAO were included within 3665 h after onset of
symptoms with a mean BCVA of 0.760.2. The median time
interval from onset of symptoms to study examination in
chronic BRAO was 19 months (4 months to 5 years) with
a mean BCVA of 0.660.3.
Course of intraretinal changes in acute BRAO
Table 1 summarises the change in segmentation results of retinal
layers in affected areas of acute BRAO compared with topo-
graphically corresponding non-affected areas in this group
during a 3-month follow-up. The subgroup analyses of
measurements at weekly intervals during the ﬁrst month are
shown in table 2. Owing to the small sample size, no statisti-
cally analyses of signiﬁcance level were performed.
At initial examination, in the BRAO area, the IPL was
increased by 80% (p<0.001) compared with corresponding non-
affected areas showing the most pronounced increase in all
retinal layers (ﬁgures 1 and 3). Moreover, in acute ischaemia, the
IPL also presented an enhanced hyper-reﬂectivity compared with
the other layers. A highly signiﬁcant increase was also measured
in the INL/OPL (48% increase, p<0.001) and the NFL/GCL layer
(35% increase, p¼0.002). The smallest change was found at the
level of the ONL with a mean increase of 21% (p¼0.003), and
Figure 2 Infrared fundus images with
the 31 superimposed spectral-domain
OCT scan lines of the patient shown in
ﬁgure 1 at acute presentation. The
central foveal scan is indicated by the
yellow line represented by scan No 16.
Scan No 19 showed the highest
macular oedema, and as this scan is
three scans apart from the central
fovea, scan No 13 was selected as the
normal counterpart in the non-involved
macular region. The selected scans in
the normal counterpart (A) and the
affected region (B) are indicated with
a red line.
Table 1 Thickness values of different retinal layers in affected areas and in topographically corresponding non-affected areas of eyes with branch
retinal artery occlusion (BRAO): monthly follow-up of eight patients with acute BRAO.
Thickness (mm, mean±SD), n[8
Non-affected
areas
Affected areas of BRAO
p Value Baseline p Value Month 1 p Value Month 2 p Value Month 3
Total retinal thickness 329625 <0.001 436637 <0.001 304628 0.002 25268 0.127 243614
Nerve ﬁbre layer+ganglion cell layer 68613 0.002 92614 <0.001 5769 0.048 4368 0.327 4264
Inner plexiform layer 4162 <0.001 74612 <0.001 3367 ee
Inner nuclear layer+outer plexiform layer 6367 <0.001 93615 <0.001 51619 ee
Inner plexiform layer+inner nuclear layer+outer plexiform layer* 10568 <0.001 167615 0.001 84625 0.022 5161* 0.303 43611*
Outer nuclear layer 9269 0.003 111610 0.006 9865 0.343 9465 0.729 9367
Photoreceptor layers+retinal pigment epithelium 6561 0.737 6662 0.753 6562 0.527 6461 0.472 6562
*At months 2 and 3, only segmentation measurements of IPL together with INL/OPL could be performed.
The inner plexiform layer (IPL) could be distinguished from the inner nuclear layer/outer plexiform layer (INL/OPL) up to month 1.p Values regarding differences in retinal layer thickness
measurements are shown in the table. On the following examinations, it was not possible to distinguish the IPL from the INL/OPL.
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Clinical sciencethe photoreceptor/retinal pigment epithelium (PR/RPE)
complex retained stable thickness values. The mean increase in
total retinal thickness in ischaemic retina compared with the
anatomically corresponding healthy counterpart was 33%
(p<0.001). This acute increase in thickness was followed by
a continuous regression of total retinal oedema by 30%
(p<0.001) at month 1, 17% (p¼0.002) at month 2 and 4% at
month 3, rendering the delineation of the speciﬁc retinal layers
of the inner retina more difﬁcult. From month 2, the IPL could
not be distinguished from the INL/OPL.
Intraretinal changes in chronic BRAO
Analysis of the nine patients with chronic BRAO revealed
a stable atrophy of inner retinal layers without any differences
between patients examined between 4 months and 5 years after
the initial event. The mean total retinal thickness of affected
areas was 21767 mm, showing a reduction of 33% (p<0.001)
when compared with the corresponding healthy counterpart
(326614 mm). SD-OCT A-scans show an intact ONL and
photoreceptor/ retinal pigment epithelium complex even in
a patient 5 years after BRAO and an atrophic inner retina
without differentiation between separate neurosensory layers
(ﬁgure 4). Table 3 summarises segmentation results.
DISCUSSION
OCT is a non-invasive imaging technology that allows for serial
monitoring of retinal alterations over time. In the literature,
there are few studies using OCT for imaging retinal changes
following CRAO/BRAO.
13e16 These data describe in detail the
in vivo changes of retinal layers after BRAO and the longitudinal
evaluation of layer thickness based on enhanced visualisation
and quantiﬁcation analyses using SD-OCT. Most importantly,
an eye-tracking system was used to allow for point-to-point
comparison during intraindividual follow-up.
In the present study, we aimed to compare the BRAO area
with the corresponding unaffected area in vivo. Therefore,
patients with CRAO were excluded from the study. Owing to
a pathological variability in patients’ ﬁxation, comparison of
CRAO eye with the healthy contralateral eye does not allow
reliable results for comparison. In our study, however, patients
with BRAO had reliable ﬁxation during OCT imaging.
Structural damage following BRAO in our and previous
studies was conﬁned to the inner retina. Interestingly, the IPL
showed the highest relative increase compared with the INL/
OPL and NFL/GCL, characterised by optical hyper-reﬂectivity of
that region with subsequent shadowing and attenuation of
optical reﬂectivity of the subjacent structures. The distinct
thickness increase in the IPL at acute presentation decresed
rapidly during follow-up, resulting in loss of differentiation
between the IPL and INL/OPL already at month 2. This suggests
that these layers are particulary involved in the pathophysiology
of BRAO.
However, when interpreting these results it should be
considered that in the acute phase of BRAO, the exact bound-
aries of different layers might be blurred, and the reﬂectivity
changes may not speciﬁcally reﬂect the exact boundaries of
retinal layers. This might be a limitation when using solely OCT
technology for identiﬁcation of structural changes in conditions
where the optical properties of the retina are probably altered,
such as in acute BRAO.
Experimental histopathological studies in rats describe
a disruption of the inner blooderetinal barrier in the hypoxic
retina with increased permeability of retinal blood vessels.
20
The central retinal artery provides the blood supply for the
inner retinal layers. The two main capillary networks arising
from the arterial branches are located at the level of the GCL
and mainly at the junction of IPL and INL. It is therefore
conceivable that ischaemia causes swelling of these layers in
the acute phase, which is conﬁrmed by changes in OCT reﬂec-
tivity and thickness in acute BRAO when compared with
anatomically corresponding healthy areas in our study. These
alterations might not only be related to ischaemia, since it has
been shown that a multitude of factors including increased
vascular endothelial growth factor and nitric oxide production,
free radicals and inﬂammatory mediators are involved in the
structural damage of retinal tissue in such conditions.
21 The
preservation of the ONL and photoreceptor/retinal pigment
epithelium complex in chronic BRAO clearly supports the
concept that these layers are supported by the choriocapillary
vasculature.
In animal models, it was proposed that the extent of retinal
damage is directly related to the duration of the ischaemic
impact.
22 Massive and irreversible retinal damage was observed
in eyes with CRAO of more than 240 min.
23 There are several
autopsy studies on human eyes with CRAO: Dahrling
24 found
diffuse oedema of inner retinal layers in one eye 60 h after
CRAO as well as a severe reduction in ganglion cells. The
increase in retinal thickness was related to intracellular oedema
in the INL and IPL, with no evidence of any ﬂuid in the extra-
cellular space originating from retinal capillaries. Deeper layers
from the INL outwards were not affected.
In our study, all patients presented at time intervals longer
than 240 min after the initial onset of the event, but it is often
difﬁcult to determine the duration of arterial occlusion and
especially the intensity of residual retinal circulation. As
expected, signiﬁcant microstructural deterioration of retinal
layers was observed within 3665 h, but because of the vari-
ability of initial presentation time, earlier intraretinal changes
could not be described in this study. A further limitation of the
study is the relatively small number of patients included.
Table 2 Thickness values of different retinal layers in affected areas and in topographically
corresponding non-affected areas of eyes with branch retinal artery occlusion (BRAO): weekly follow-up
of three patients with acute BRAO during the ﬁrst month
Thickness (mm, mean±SD), n[3
Non-affected
areas
Affected areas of BRAO
Baseline Week 1 Week 2 Week 3 Week 4
Total retinal thickness 338618 439631 407621 380619 349614 312617
Nerve ﬁbre layer+ganglion cell layer 71669 6 658 2 668 0 677 7 676 3 66
Inner plexiform layer 43637 2 676 9 685 8 694 5 653 3 68
Inner nuclear layer+outer plexiform layer 61689 1 610 84612 75610 63685 6 64
Outer nuclear layer 9966 11768 10865 102669 8 659 6 66
Photoreceptor layers+retinal pigment epithelium 64626 5 616 4 636 5 626 6 626 4 62
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Clinical scienceIn conclusion, this report describes in vivo changes in the
ultrastructure of neurosensory layers in BRAO at acute presen-
tation and during follow-up. Segmentation of distinct layers
revealed a selective and pronounced swelling of inner retinal
layers, from the NFL and GCL down to the INL and IPL, while
the deeper layers such as ONL were only discretely or not
affected at all such as PR/RPE, which were well preserved even
after longstanding ischaemia by month and years. Hence,
SD-OCT allowed a detailed in vivo documentation of topo-
graphic oxygen dependence and consecutively ischaemia-related
localised alteration of the inner portion of neurosensory layers
dependent on the supply of the retinal vasculature. The barrier
Figure 3 (AeD) Occlusion of the
infertior temporal artery in the left eye,
showing an oedematous area along the
inferior temporal branch and a partially
compromised fovea. Serial spectral-
domain OCT macular thickness maps
and high resolution A scans across the
fovea recorded at day 0 (A), month 1
(B), month 2 (C) and month 3 (D). The
scans show an increase in retinal
thickness in the inferior macula as
a result of oedema in the inner retinal
layers. The oedema subsequently
resolved at month 1 (B) with decreasing
macular thickness at month 2 (C). (E, F)
Infrared fundus images with the
superimposed OCT scan-lines and the
selected B-scans for segmentation
measurements at baseline. The central
foveal scan is indicated by the yellow
line, and the selected scans in the
normal counterpart (E) and the affected
region (F) are indicated with a red line.
(G) Fluorescein angiography showing
asymetry in vascular ﬁlling in the early
phase of the examination.
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Clinical sciencebetween retinal and choroidal oxygenation is obviously repre-
sented by the ONL showing the least morphological response.
Regression of total retinal thickness was highest during the ﬁrst
month (30%, p<0.001), less pronounced during the second
(17%, p¼0.002) and not statistically signiﬁcant during the third
month (4%) (ﬁgure 3). These in vivo data may offer an excellent
insight into pathophysiology of retinal ischaemia including
topography and time-course of neurosensory change.
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